Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Jan 2;31(1):141-143.
doi: 10.21873/invivo.11037.

Clozapine Associated with Autoimmune Reaction, Fever and Low Level Cardiotoxicity - A Case Report

Charilaos Gerasimou  1 , Georgia Phaedra Vitali  1 , George D Vavougios  2   3 , Charalabos Papageorgiou  4 , Athanasios Douzenis  1 , Styliani I Kokoris  4 , Ioannis Liappas  5 , Emmanouil Rizos  6
Affiliations
Case Reports

Clozapine Associated with Autoimmune Reaction, Fever and Low Level Cardiotoxicity - A Case Report

Charilaos Gerasimou et al. In Vivo. .

Abstract

Background: Clozapine is a second-generation antipsychotic drug used in treatment-resistant schizophrenia. Fever induced by clozapine is a rather frequent side-effect which usually occurs in the first 4 weeks of treatment. Despite its effectiveness, there are potentially life-threatening adverse effects, such as cardiotoxicity.

Case report: We present the case of a 31-year-old caucasian male with refractory schizophrenia who developed benign fever, increase of C-reactive protein and high troponin levels, without presenting any other signs to myocarditis, on the 13th day under clozapine treatment, which declined progressively upon discontinuation of the drug.

Discussion: This case hints at the presence of initially subclinical cardiotoxicity as an underlying factor in patients developing fever.

Conclusion: Taking advantage of more sensitive methods for measuring troponin, clinicians would be promptly aware of this possible side-effect. This would allow for significant reduction of the risk of cardiac dysfunction, further attained by carefully monitoring the patient.

Keywords: Cardiotoxicity; case report; clozapine; fever; schizophrenia.

PubMed Disclaimer

References

    1. Patel SS, Allin MP. Physical complications in early clozapine treatment: a case report and implications for safe monitoring. Ther Adv Psychopharmacol. 2011;v1(1):25–29. - PMC - PubMed
    1. Lally J, Gaughram F, Timms P, Curran SR. Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics. Pharmgenomics Pers Med. 2016;9:117–129. - PMC - PubMed
    1. Røge R, Møller BK, Andersen CR, Correll CU, Nielsen J. Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far? Schizophr Res. 2012;140(1-3):204–213. - PubMed
    1. Abdel-Wahab BA, Metwally ME. Clozapine-induced cardiotoxicity. Role of oxidative stress, tumour necrosis factor alpha and NF-ĸβ. Cardiovasc Toxicol. 2015;15(4):355–365. - PubMed
    1. Pollmächer T, Haack M, Schuld A, Kraus T, Hinze-Selch D. Effects of antipsychotic drugs on cytokine networks. J Psychiatr Res. 2000;34(6):369–382. - PubMed

Publication types